Abivax sets its course on colitis and Crohn’sFrench biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 Share XAbivax sets its course on colitis and Crohn’shttps://pharmaphorum.com/news/abivax-scolitis-crohns/
Study indicates potential breakthrough HIV drugFrench biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant Share XStudy indicates potential breakthrough HIV drughttps://pharmaphorum.com/news/study-indicates-breakthrough-hiv/
AbiVax claims progress towards HIV cureFrench biotech to step up clinical development of ABX464. Share XAbiVax claims progress towards HIV curehttps://pharmaphorum.com/news/abivax-aims-hiv-cure-new-antiretroviral-pill/
